Physician profile
Bridget Skinner
NPI 1316117096
$25,171.92
in general payments reported to CMS, 2019-2025
71 companies · $3,846 in 2025
The $3,846 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,148 · 2022: $5,339 · 2023: $5,700 · 2024: $7,139 · 2025: $3,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,524.04 |
| Education | $160.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,164.15 | 2021-2025 | |
| Emd Serono, INC. | $1,994.06 | 2021-2025 | Mavenclad, Mavenclad |
| Ucb, INC. | $1,916.43 | 2021-2025 | Briviact, Nayzilam, Rystiggo |
| Abbvie INC. | $1,867.53 | 2021-2025 | |
| Genzyme Corporation | $1,477.95 | 2021-2025 | |
| Biogen, INC. | $1,139.23 | 2021-2025 | Tysabri, Vumerity, Avonex |
| Teva Pharmaceuticals USA, INC. | $882.27 | 2021-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $864.10 | 2021-2025 | Ingrezza, Ongentys |
| Celgene Corporation | $854.54 | 2021-2025 | Zeposia |
| Lilly USA, LLC | $677.51 | 2021-2025 | Emgality, Reyvow, Kisunla |
| Janssen Pharmaceuticals, INC | $620.58 | 2021-2023 | |
| Pfizer INC. | $613.67 | 2021-2025 | |
| Tg Therapeutics, INC. | $489.26 | 2022-2025 | |
| Argenx US, INC. | $489.24 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $478.57 | 2021-2025 | Ultomiris, Soliris |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $466.67 | 2022-2025 | Valtoco |
| Alnylam Pharmaceuticals INC. | $460.45 | 2021-2025 | Onpattro, Amvuttra |
| Amgen INC. | $451.25 | 2021-2025 | Uplizna, Aimovig |
| Acadia Pharmaceuticals INC | $379.83 | 2021-2025 | Nuplazid |
| Sk Life Science, INC. | $367.17 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $361.19 | 2022-2025 | Hyqvia, Gammagard |
| Lundbeck LLC | $358.34 | 2021-2025 | Vyepti, Rexulti |
| Eisai INC. | $348.05 | 2021-2025 | |
| Catalyst Pharmaceuticals, INC. | $344.75 | 2021-2025 | Firdapse |
| Astrazeneca Pharmaceuticals LP | $327.02 | 2022-2025 | Wainua, Andexxa |
| Scilex Pharmaceuticals INC. | $289.76 | 2021-2024 | Ztlido |
| Ani Pharmaceuticals, INC. | $285.59 | 2022-2025 | Purified Cortrophin Gel |
| Otsuka America Pharmaceutical, INC. | $278.88 | 2023-2025 | Rexulti, Nuedexta |
| Amneal Pharmaceuticals LLC | $262.79 | 2021-2025 | Crexont, Rytary |
| Csl Behring | $255.52 | 2021-2025 | Hizentra |
| Genentech USA, INC. | $246.61 | 2023-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Biohaven Pharmaceutical Holding Company LTD. | $239.07 | 2022 | |
| Kyowa Kirin, INC. | $222.83 | 2021-2024 | Nourianz |
| Horizon Therapeutics Plc | $215.77 | 2021-2023 | Uplizna |
| Biohaven Pharmaceuticals, INC. | $203.03 | 2021 | |
| Corium, LLC | $196.90 | 2022-2023 | Adlarity |
| Allergan, INC. | $141.61 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $137.30 | 2021-2025 | Acthar |
| Axsome Therapeutics, INC. | $133.05 | 2024-2025 | Symbravo, Sunosi |
| Sumitomo Pharma America, INC. | $128.63 | 2024 | Aptiom |
| Vanda Pharmaceuticals INC. | $126.71 | 2021-2025 | Ponvory |
| Octapharma USA, INC. | $120.51 | 2023-2025 | Panzyga |
| E.R. Squibb & Sons, L.L.C. | $115.14 | 2021-2024 | Zeposia |
| Acorda Therapeutics, INC | $113.59 | 2022-2024 | Inbrija |
| Avanir Pharmaceuticals, INC. | $111.71 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $101.95 | 2022-2025 | |
| Tanabe Pharma America, INC. | $88.66 | 2023-2025 | Radicava |
| Supernus Pharmaceuticals, INC. | $88.25 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $83.36 | 2024-2025 | Tascenso Odt, Bafiertam, Ormalvi |
| Cala Health, INC. | $80.88 | 2022-2023 | Cala Trio, Cala Kiq |
| Upsher-Smith Laboratories LLC | $65.70 | 2021-2023 | |
| Impel Pharmaceuticals INC. | $62.22 | 2023 | Trudhesa |
| Validus Pharmaceuticals LLC | $37.03 | 2023 | Equetro |
| Azurity Pharmaceuticals, INC. | $30.68 | 2023-2024 | Horizant, Horizant |
| Avion Pharmaceuticals | $29.21 | 2022 | |
| Averitas Pharma INC. | $26.49 | 2024 | Qutenza |
| Merz Pharmaceuticals, LLC | $25.19 | 2024 | Inbrija |
| Xeris Pharmaceuticals, INC. | $25.10 | 2025 | Keveyis |
| Grifols USA, LLC | $24.22 | 2023 | Gamunex-C |
| Sanofi-Aventis U.S. LLC | $23.57 | 2021 | |
| Mdd US Operations, LLC | $19.38 | 2021 | |
| Sobi, INC | $18.13 | 2021 | |
| Hospira, INC. | $16.41 | 2025 | |
| Owp Pharmaceuticals, INC. | $15.29 | 2023 | Subvenite, Lamotrigine |
| Collegium Pharmaceutical, INC. | $14.92 | 2022 | |
| Abbott Laboratories | $14.40 | 2021 | |
| Adamas Pharmaceuticals, INC. | $14.30 | 2021 | |
| Currax Pharmaceuticals LLC | $13.79 | 2021 | |
| Alfasigma USA, INC. | $12.13 | 2022 | |
| Biodelivery Sciences International, INC. | $11.13 | 2021 | |
| Aucta Pharmaceuticals, INC. | $10.72 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
Kesimpta $1,616Mavenclad $704Zeposia $610Ingrezza $609Briviact $517Nayzilam $494Botox $490Nurtec Odt $486Ubrelvy $474Briumvi $457Tysabri $435Qulipta $379Valtoco $359Austedo Xr $317Nuplazid $316Onpattro $297Vumerity $278Rexulti $256Leqembi $242Vyvgart $237Wainua $237Zavzpret $232Panzyga $221Ajovy $221Vyepti $215Duopa $202Vyvgart Hytrulo $200Rystiggo $199Ultomiris $196Purified Cortrophin Gel $194Adlarity $181Ocrevus $177Hyqvia $173Ongentys $156Avonex $149Hizentra $139Emgality $133Aptiom $129Ztlido $118Reyvow $118Gammagard $117Firdapse $116Enspryng $113Uplizna $111Kisunla $111Fintepla $107Vraylar $107Ponvory $107Amyvid $107Symbravo $101Aubagio $101Octagam Immune Globulin (Human) $100Nourianz $99.57Comirnaty $93.64Nuedexta $90.53Ocrevus Zunovo $89.72Radicava $88.66Andexxa $84.41Epidiolex $83.92Crexont $81.86Rytary $77.96Paxlovid $72.25Skyclarys $70.42Austedo $68.71Tascenso Odt $67.70Inbrija $65.92Soliris $64.15Fycompa $62.26Trudhesa $62.22Amvuttra $61.75Vyalev $60.05Radicava Ors $56.85Cala Trio $52.71Spinraza $44.57Acthar $38.35Equetro $37.03Nexviazyme $36.00Sunosi $32.04Horizant $30.68Qutenza $26.49Keveyis $25.10Gamunex-C $24.22Agamree $24.07Bafiertam $22.56Aimovig $18.92Cala Kiq $16.21Ormalvi $15.66Lamotrigine $15.29Subvenite $15.29Zembrace Symtouch $14.91Motpoly Xr $10.72
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Skinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.